JNJ - Johnson & Johnson - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4781601046

Medicines, Medical Devices, Contact Lenses, Surgical Tools, Orthopedic Implants

Johnson & Johnson is a global healthcare leader that researches, develops, manufactures, and sells a wide range of products to improve human health and well-being. With a rich history dating back to 1886, the company is headquartered in New Brunswick, New Jersey.

The company's Innovative Medicine segment is a pioneer in developing innovative treatments for various therapeutic areas. These areas include immunology, where they offer solutions for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. They also provide treatments for infectious diseases such as HIV/AIDS, as well as neuroscience solutions for mood disorders, neurodegenerative disorders, and schizophrenia. Additionally, they have a strong presence in oncology, with treatments for prostate cancer, hematologic malignancies, lung cancer, and bladder cancer. Furthermore, they offer products for cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration, as well as pulmonary hypertension treatments.

The MedTech segment is another crucial part of Johnson & Johnson's business. This segment provides a range of innovative solutions, including Interventional Solutions for electrophysiology, heart recovery, and neurovascular care. They also offer an orthopaedics portfolio that includes products and enabling technologies for hips, knees, trauma, spine, sports, and other areas. Moreover, they have a comprehensive surgery portfolio that includes advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures. Their contact lenses, under the ACUVUE Brand, are a popular choice for many consumers. Additionally, they offer TECNIS intraocular lenses for cataract surgery.

Johnson & Johnson distributes its products to a wide range of customers, including wholesalers, hospitals, retailers, physicians, nurses, hospitals, eye care professionals, and clinics. With a strong commitment to innovation and customer satisfaction, the company continues to be a leader in the healthcare industry.

For more information about Johnson & Johnson, please visit their website at https://www.jnj.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for JNJ - Johnson & Johnson  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for JNJ - Johnson & Johnson  - Stock Price & Dividends

JNJ Stock Overview

Market Cap in USD 350,894m
Sector Healthcare
Industry Drug Manufacturers - General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1944-09-24

JNJ Stock Ratings

Growth 5y 24.0
Fundamental 76.2
Dividend 53.30
Rel. Performance vs Sector -1.18
Analysts 3.83/5
Fair Price Momentum 139.25 USD
Fair Price DCF 204.88 USD

JNJ Dividends

Dividend Yield 12m 3.21%
Yield on Cost 5y 4.10%
Dividends CAGR 5y 4.62%
Payout Consistency 100.0%

JNJ Growth Ratios

Growth 12m -3.31%
Growth Correlation 12m -38%
Growth Correlation 3m 4%
CAGR 5y 4.99%
CAGR/Mean DD 5y 0.76
Sharpe Ratio 12m -0.54
Alpha vs SP500 12m -20.70
Beta vs SP500 5y weekly 0.57
ValueRay RSI 82.95
Volatility GJR Garch 1y 15.56%
Price / SMA 50 1.37%
Price / SMA 200 -1.17%
Current Volume 5335.4k
Average Volume 20d 6520.4k

External Links for JNJ Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of JNJ stocks?
As of July 14, 2024, the stock is trading at USD 149.88 with a total of 5,335,386 shares traded.
Over the past week, the price has changed by +2.32%, over one month by +3.07%, over three months by +2.42% and over the past year by -2.83%.
What are the forecast for JNJ stock price target?
According to ValueRays Forecast Model, JNJ Johnson & Johnson will be worth about 152.6 in July 2025. The stock is currently trading at 149.88. This means that the stock has a potential upside of +1.84%.
Issuer Forecast Upside
Wallstreet Target Price 172 14.7
Analysts Target Price 168.5 12.4
ValueRay Target Price 152.6 1.84

Johnson & Johnson: Navigating Through History to Modern Success

History at a Glance

Johnson & Johnson (J&J), founded in 1886 by three Johnson brothers, Robert, James, and Edward, began its journey with the aim of producing sterile surgical supplies. This innovation marked the start of a company that would grow to become a cornerstone in the healthcare industry, paving the way with its commitment to improving health for people worldwide.

Core Businesses

J&J has strategically branched out into three main sectors over the years: Pharmaceuticals, Medical Devices, and Consumer Health Products. The Pharmaceuticals division focuses on researching and developing medications for various diseases. The Medical Devices sector offers a wide range of health care products used by professionals. Lastly, the Consumer Health Products division brings everyday health and personal care products to consumers worldwide.

Side Businesses and Diversification

Beyond its primary operations, J&J has also ventured into areas such as digital health solutions and acquisitions that complement its core businesses. This diversification not only expands J&J’s portfolio but also strengthens its position in the healthcare market by meeting a broader range of consumer and medical needs.

Current Market Status

As of today, Johnson & Johnson stands as a giant in the healthcare field, with a strong presence on the New York Stock Exchange (NYSE: JNJ). Despite the complexities and competitive nature of the healthcare industry, J&J has demonstrated resilience and growth. Its commitment to innovation, research, and development continues to drive the company forward, ensuring its place as a leader in providing healthcare solutions.